Whole body fluorescence imaging of mice was performed with LI-COR Biosciences Odyssey Infrared Imaging System with emission wavelength at 700 nm (for verteporfin) and 800 nm (for Cy7-BSA). The nu/nu mice were first subcutaneously inoculated with 5 × 104 4T1 cells in 50 µL PBS (1×) into the back of neck. Similar to the descriptions above, IMOD with verteporfin loaded optical fiber was implanted once tumor length was determined to be approximately 8 mm. The nu/nu mice were fed with alfalfa-free food for at least one week prior to the study in order to minimize the gastrointestinal background autofluorescence90. For imaging studies, 100 µg/mL Cy7-BSA in 30 µL sterile PBS (1×) was injected through the refillable tubing on IMOD into the 4T1 tumor after PDT irradiation. Fluorescence images of nu/nu mice were taken at designated time points. The analysis of the results was carried out using Origin software (Northampton, MA) by fitting the normalized fluorescence intensity (I) – time (t) curve into an exponential decay model according to Eq. (1).
where a, b, T1 are all constants fitted by Origin software. The starting point for the curve fitting was the peak value of the normalized fluorescence intensity, usually at 4 or 12 h. The obtained T1 value was used to calculate the decay half-life τ based on Eq. (2).
Note that the fluorescence intensity at t = 0 was normalized as 1.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.